Wells Fargo raises Colgate-Palmolive stock price target on solid Q3
Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.
How this was made
The 30-second read
Why it matters
The upgrades may attract short‑term buying interest, but high valuation could temper long‑term gains.
Market read
Analyst upgrades on a earnings beat provide a fresh catalyst for CL, suggesting modest upside potential.
What to watch
Material‑cost pressure of ~300 bps and ongoing tariff/logistics challenges may curb future margin expansion.
Background
Colgate-Palmolive reported Q3 2026 earnings that beat expectations, prompting analyst target raises.
Ticker impact
Wells Fargo raised its price target for Colgate-Palmolive to $95 from $90 and UBS raised its target to $112, following the company's Q3 2026 earnings beat.
likely modest upside as the market prices in the higher price targets
Both major banks increased targets on better‑than‑expected earnings, indicating improved earnings outlook and margin performance.
Market effects
Consumer staples may benefit from demonstrated pricing power and margin resilience.
Emerging‑market exposure (India, Brazil, China) supports broader market optimism in those regions.
Reinforces confidence in consumer‑goods earnings stability amid volatile macro conditions.
Counterpoint
Valuation remains high (P/E ~38) and inflation pressures could limit upside.
Key entities
- analystWells Fargo
Raised CL price target to $95.
- analystUBS
Raised CL price target to $112.
